The initial interaction of oxygen with a Cu(ll0) surface occurs in two stages, character&d by (2 X 1) and ~$6 X 2) overlayer structures and then a third stage where the cf6 X 2) structure remains but further oxygen uptake is registered only with e~psometry. The fust stage is nonactivated and is accornp~~~ by a work function increase of 370-420 meV, depending on sample temperature. The subsequent appearance of the extra features associated with the c(6 X 2) structure in the second stage is accompanied by a decrease in work function of -100 meV and is characterised by an apparent activation energy of -18 M mol-r . The adsorbed oxygen can be removed at all coverages by gas-phase CO. The reaction appears to foHOw Langmuir-Hiishelwood kinetics with an apparent activation energy of -25 M mol-' .
fntroductionThe interaction of oxygen with the (110) surface of copper results in the initial formation of a (2 X 1) surface structure which is assumed to correspond to 0.5 monolayers [l--4]. Further oxygen exposure produces a ~(6 X 2) structure f5]. The first stage of the interaction is known to be accompanied by an increase in work function. Thus Ertl and Kiippers [6] have reported an increase of 0.2 eV after an exposure of 6 L and Delchar f7] a m~~urn increase of 0.67 eV after 2 X 10" L at room temperature. Delchar established that a change of 0.40 eV had already been reached after about 100 L. On the (100) surface a similar reaction sequence has been observed. The formation of the initial (u/z X 42) R45" structure is accompanied by an increase in the work function as might be expected, but the formation of the subsequent (d2 X 242) R4.5" structure by a decrease [8,9]. This has been 285
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.